Keyword search

Sort Help
entries

Results

All (57)

All (57) (20 to 30 of 57 results)

  • Articles and reports: 88-003-X20040037440
    Geography: Canada
    Description:

    Theories of business growth lead us to believe that, to grow, a company needs to be innovative, conduct research and development, have access to multiple sources of funding, protect its intellectual property, engage in alliances and establish itself in a market niche. In this article, interviews with Canadian technology-based companies show that some companies manage to grow by breaking these rules.

    Release date: 2004-10-29

  • Articles and reports: 88-003-X20040037441
    Geography: Canada
    Description:

    This article examines average research and development spending per firm and revenue growth. Using data from the Survey of Research and Development in Canadian Industry, it explores differences in research and development spending and revenue growth between high-growth and non-high-growth firms that reported strong employment growth.

    Release date: 2004-10-29

  • Articles and reports: 88-003-X20040037427
    Geography: Canada
    Description:

    A series of working papers on the transition from small to medium size is being derived from a joint project of Statistics Canada and the National Research Council's Industrial Research Assistance Program (NRC-IRAP). The project developed out of a need to better understand how and why certain businesses grow.

    Release date: 2004-10-29

  • Articles and reports: 88F0006X2004017
    Description:

    Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.

    Release date: 2004-10-22

  • Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30

  • Articles and reports: 88F0006X2004007
    Description:

    This paper presents data on technological change that have been made comparable from the Survey of Electronic Commerce and Technology (SECT) for 2000 and 2002. It shows that when comparable data for the 1998 to 2000 and 2000 to 2002 periods (based on the definition and survey universe employed by SECT 2000) are used, the propensity to adopt new technologies in the private sector has remained constant at about 40%. The rate of technology adoption in the public sector remained at four out of five organizations introducing significantly improved technologies (a level about twice as high as that for the private sector). This rate also shows little change from 2000. The paper presents the comparable technological change data, while explaining differences in the wording of the survey questions and universe between the two reference years. Information is provided for private and public sectors, selected employment size groups and sectors of both private and public sectors.

    Release date: 2004-03-09

  • Articles and reports: 88-003-X20040016791
    Geography: Canada, Province or territory
    Description:

    Data from the 2001 Biotechnology Use and Development Survey reveal that there are 133 biotechnology Canadian-based firms manufacturing or developing bioproducts. These mostly private 'home-grown' firms, located in Quebec, British Columbia and Ontario, are operating across all economic sectors. The largest share of their combined portfolio of 805 bioproducts is at the commercialization stage. Bioprocessing-based bioproducts (products developed or made using enzymes and bacteria culture) lead the way.

    Release date: 2004-03-05

  • Articles and reports: 88F0006X2004006
    Description:

    Biotechnology is a pervasive technology used in several industrial sectors, making collecting sound data a real challenge. This paper describes the methodology of the Biotechnology Use and Development Survey. Some of the specific issues dealt with are the definitions of biotechnology and innovative biotechnology firms, the target population, sampling, data collection procedures, and data quality evaluation.

    Release date: 2004-03-05

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27

  • Articles and reports: 88-003-X20030026571
    Geography: Canada
    Description:

    This article presents the results of a study that looks at the characteristics of Canadian biotechnology firms that form strategic alliances and measures the impact that such alliances have on their performance indicators.

    Release date: 2003-06-27
Data (3)

Data (3) ((3 results))

Analysis (54)

Analysis (54) (20 to 30 of 54 results)

  • Articles and reports: 88F0006X2004017
    Description:

    Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.

    Release date: 2004-10-22

  • Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30

  • Articles and reports: 88F0006X2004007
    Description:

    This paper presents data on technological change that have been made comparable from the Survey of Electronic Commerce and Technology (SECT) for 2000 and 2002. It shows that when comparable data for the 1998 to 2000 and 2000 to 2002 periods (based on the definition and survey universe employed by SECT 2000) are used, the propensity to adopt new technologies in the private sector has remained constant at about 40%. The rate of technology adoption in the public sector remained at four out of five organizations introducing significantly improved technologies (a level about twice as high as that for the private sector). This rate also shows little change from 2000. The paper presents the comparable technological change data, while explaining differences in the wording of the survey questions and universe between the two reference years. Information is provided for private and public sectors, selected employment size groups and sectors of both private and public sectors.

    Release date: 2004-03-09

  • Articles and reports: 88-003-X20040016791
    Geography: Canada, Province or territory
    Description:

    Data from the 2001 Biotechnology Use and Development Survey reveal that there are 133 biotechnology Canadian-based firms manufacturing or developing bioproducts. These mostly private 'home-grown' firms, located in Quebec, British Columbia and Ontario, are operating across all economic sectors. The largest share of their combined portfolio of 805 bioproducts is at the commercialization stage. Bioprocessing-based bioproducts (products developed or made using enzymes and bacteria culture) lead the way.

    Release date: 2004-03-05

  • Articles and reports: 88F0006X2004006
    Description:

    Biotechnology is a pervasive technology used in several industrial sectors, making collecting sound data a real challenge. This paper describes the methodology of the Biotechnology Use and Development Survey. Some of the specific issues dealt with are the definitions of biotechnology and innovative biotechnology firms, the target population, sampling, data collection procedures, and data quality evaluation.

    Release date: 2004-03-05

  • Articles and reports: 88-003-X20030026570
    Geography: Canada
    Description:

    In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?

    Release date: 2003-06-27

  • Articles and reports: 88-003-X20030026571
    Geography: Canada
    Description:

    This article presents the results of a study that looks at the characteristics of Canadian biotechnology firms that form strategic alliances and measures the impact that such alliances have on their performance indicators.

    Release date: 2003-06-27

  • Articles and reports: 88-001-X20030047882
    Description:

    Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology Research and Development by sector of application and to reveal trends in spending.

    Release date: 2003-06-05

  • Articles and reports: 88F0006X2003005
    Description:

    The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2001 Biotechnology Use and Development Survey. Within the last few years, except for the amount of financing capital raised, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 358 in 1999 to 375 in 2001. The Human Health sector outpaces all the other sectors in terms of the number of firms, human resources, biotechnology revenues, biotechnology research and development expenditures, amount of financing capital raised, and the number of products in the pipeline. Contrary to medium-sized and large firms where the personnel is more homogenous, small firms employ mostly highly-qualified workers. The 2001 data show a maturing trend in small firms. Most firms could not hire enough people to fill all their vacancies (estimated at 953 positions in Canada) for the 2001 year.

    Release date: 2003-03-28

  • Articles and reports: 88F0006X2003003
    Description:

    Results show that biotechnology companies in Canada are experiencing rapid growth and that Statistics Canada is now capturing more biotechnology activity. For example, between 1997 and 1999, Canadian biotechnology firms grew in number with core biotechnology firms increasing from 282 firms to 358. They brought in $1.9 billion in biotechnology revenues in 1999, compared with $813 million in 1997; they spent around $827 million on biotechnology research and development in 1999, compared with $494 million in 1997.

    Release date: 2003-03-10
Reference (0)

Reference (0) (0 results)

No content available at this time.